Radial artery

EQL BAND Aims to Silence Green Light Bias In Smartwatches with the Power of Sound

Retrieved on: 
Wednesday, November 15, 2023
Health equity, Hertz, Research, CBPF, White Americans, Breast cancer, Culture, Data collection, Wrist, Wellness, Diagnosis, Partnership, Doctor of Philosophy, Ear, Bias, Skin, Radial artery, Medical imaging, Black, Physics, Health

More than 70 million Americans rely on smartwatches to track their health and use the data generated to inform lifestyle and treatment decisions.

Key Points: 
  • More than 70 million Americans rely on smartwatches to track their health and use the data generated to inform lifestyle and treatment decisions.
  • EQL Band is the manifestation of exactly that – we reimagined smartwatch technology, to create a product that’s accurate and equitable for all.
  • EQL Band is an innovation born from necessity, the necessity of clinical equality,” said Kathleen Nanda, Chief Creative Officer at FCB Health New York.
  • Recently, EQL Band took home four awards at the LIA Awards 2023 including Golds for “Evolution: Product Innovation” and “Design: Prototype” and medals in Health & Wellness categories “Prototype” and “Innovation.”

Merit Medical Launches Expanded Maestro® Microcatheter Line

Retrieved on: 
Tuesday, October 10, 2023
Embolism, Bleeding, Wrist, MD, Femoral artery, Health, Patient satisfaction, Anatomy, Maestro, Blood, Neck, Radial artery, MMSI, Groin, Patient, Medical imaging

SOUTH JORDAN, Utah, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the expansion of its Maestro Microcatheter product line to now include a new longer length for radial embolization procedures.

Key Points: 
  • SOUTH JORDAN, Utah, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the expansion of its Maestro Microcatheter product line to now include a new longer length for radial embolization procedures.
  • The new 165-cm Maestro length will be available in 2.1F, 2.4F, 2.8F, and 2.9F catheter diameters to support a broad range of embolization procedures.
  • “Merit Maestro’s longer length is ideal for radial access,” said Mary Costantino, MD, interventional radiologist at Advanced Vascular Centers in Oregon, and a paid consultant of Merit.
  • Radial artery access is a minimally invasive approach to diagnosing and treating a wide range of medical conditions.

MicroVention Enters Transradial Access Therapy; Receives FDA Clearance of SOFIA™ EX 5F 115cm Intracranial Support Catheter

Retrieved on: 
Thursday, September 21, 2023
Biotechnology, Medical Supplies, Surgery, Health, FDA, Medical Devices, Hospitals, Other Health, Wrist, Radial artery, Terumo, Transradial catheterization, EX, Patient, PTFE, Soft, Femoral artery, Groin, Medical device

MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced that the SOFIA™ EX 5F 115 cm Intracranial Support Catheter (Soft TOrqueable catheter For Intracranial Access) has received FDA 510(k) clearance on September 15, 2023, for transradial access in addition to transfemoral access.

Key Points: 
  • MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced that the SOFIA™ EX 5F 115 cm Intracranial Support Catheter (Soft TOrqueable catheter For Intracranial Access) has received FDA 510(k) clearance on September 15, 2023, for transradial access in addition to transfemoral access.
  • The SOFIA™ EX 5F radial access clearance proudly marks MicroVention’s first radial access product and signifies our commitment to innovation.
  • MicroVention believes providers should have the ability to feel confident in our SOFIA™ EX 5F in either the transradial or transfemoral access approach.
  • “We are pleased to receive FDA clearance for MicroVention’s SOFIA™ EX 5F Intracranial Support Catheter for transradial access,” said Carsten Schroeder, CEO, MicroVention.

New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients

Retrieved on: 
Monday, March 6, 2023
Health, Surgery, Neurology, Medical Devices, SVV, Pulse, MASI, Patient, Multimedia, British Journal of Neurosurgery, Craniotomy, Radial artery, PVI, Medical imaging, Neurosurgery

The researchers concluded that “PVi and SVV are equally effective for guiding intraoperative goal-directed fluid therapy in adult neurosurgical patients scheduled for elective craniotomy for supratentorial brain tumors.

Key Points: 
  • The researchers concluded that “PVi and SVV are equally effective for guiding intraoperative goal-directed fluid therapy in adult neurosurgical patients scheduled for elective craniotomy for supratentorial brain tumors.
  • In the PVi group, patients were monitored using Masimo Radical-7® Pulse CO-Oximeters® with noninvasive pulse oximetry fingertip sensors.
  • In the SVV group, SVV was invasively measured using an Edwards Lifesciences Vigileo/FloTrac device connected to a cannulated radial artery.
  • This suggests that PVi, derived noninvasively from the pulse oximetry waveform, is a reliable indicator of fluid responsiveness.”

Imperative Care Announces FDA Clearance and Initial Cases of Zoom RDL, the First Stroke-Specific Radial Access Platform for Mechanical Thrombectomy

Retrieved on: 
Wednesday, January 4, 2023
General Health, Neurology, FDA, Medical Devices, Health, Stroke, Food, Spectrum Health, LDP, Anatomy, Zoom, Thrombectomy, Brain, Patient, Physician, Feedback, FDA, Food and Drug Administration, Radial artery, Pharmaceutical industry

Imperative Care, Inc. , today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Zoom™ RDL Radial Access System, the company’s latest innovation in elevating stroke care and the first radial access platform developed specifically for ischemic stroke treatment.

Key Points: 
  • Imperative Care, Inc. , today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Zoom™ RDL Radial Access System, the company’s latest innovation in elevating stroke care and the first radial access platform developed specifically for ischemic stroke treatment.
  • Zoom RDL is the newest addition to Imperative Care’s Zoom Stroke Solution™, the company’s ischemic stroke product portfolio that includes the Zoom 88 Large Distal Platform (LDP) for neurovascular access, four purposefully designed vessel-matching Zoom Aspiration Catheters, and the powerful Zoom Pump with Zoom POD for sterile-field clot capture.
  • The Zoom RDL was used during treatment of an acute stroke for a patient with a complex anatomy that would have made femoral access challenging.
  • Similar to the company’s FDA-cleared Zoom 88 Large Distal Platform for femoral access, Zoom RDL features a large .088” lumen for compatibility with large-bore aspiration catheters.

PTA Balloon Catheter Market Report 2022: Increasing Prevalence of Cardiovascular Disease Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 8, 2022
Health, Surgery, Cardiology, Medical Devices, Degenerative disease, Arm, Leg, Medtronic, Boston Scientific, CVD, Cardinal Health, Global Health, Skin, Prevalence, Dilation, US, BD (company), PTA, LASI, Femoral artery, Death, Circulatory system, Growth, Application, Marketing, Region, Radial artery, Cardiovascular disease, Cook Group, Renewable energy, Pharmaceutical industry, Synthetic rubber

The "PTA Balloon Catheter Market, by Material Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "PTA Balloon Catheter Market, by Material Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • PTA balloon catheter is an innovative medical device, which is inserted in the femoral artery in the leg or sometimes into the radial artery in the arm for the treatment of constricted blood vessels.
  • As the balloon inflates, the cage causes the balloon to form a series of segmented pillows and grooves along the entire lesion.
  • The standard PTA balloon catheter segment has represented the largest share of the total PTA balloon catheter market.

Merit Medical Launches the PreludeSYNC EZ™ Radial Compression Device

Retrieved on: 
Monday, November 21, 2022
Endoscopy, Heart, Bleeding, Femoral artery, MMSI, Blood, Wrist, Hospital, PCI, Radiology, EZ, Critical care, Percutaneous coronary intervention, Cardiology, Radial artery, Hemostasis, Radial, Medical imaging

SOUTH JORDAN, Utah, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of the PreludeSYNC EZ Radial Compression Device.

Key Points: 
  • SOUTH JORDAN, Utah, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of the PreludeSYNC EZ Radial Compression Device.
  • Created with the patient and clinician in mind, the PreludeSYNC EZ provides a simplified alternative to the two-strap compression band currently on the market.
  • 3 Benefits include fewer bleeding complications, improved patient comfort, and decreased procedure costs compared to femoral procedures, or those performed through the femoral artery in the groin.3
    Learn more about the PreludeSYNC EZ Radial Compression Device.
  • Merit Medical is fully invested in being a leader in radial artery access, said Fred P. Lampropoulos, Merit Medicals Chairman and CEO.

LIVEMETRIC RECEIVES FDA CLEARANCE FOR ITS WATCH-LIKE WEARABLE BLOOD PRESSURE MONITORING TECHNOLOGY, A LONG-AWAITED REVOLUTION IN CUFF-FREE HYPERTENSION MONITORING

Retrieved on: 
Thursday, June 30, 2022
Efficiency, Diagnosis, FDA, Patient, Blood pressure, Caregiver, Holter, Behavior, Food and Drug Administration, Nano, Food, BP, CE, University, Cardiovascular disease, Degenerative disease, Hypertension, ABPM, VP, Chicago (franchise), Radial artery, MD, Algorithm, MEMS, Pharmaceutical industry, Medical device, Medicine

DENVER and LUXEMBOURG, June 30, 2022 /PRNewswire/ -- LiveMetric, a leader in medical wearable technology, today announced the launch of LiveOne, the world's first 510(k) U.S. Food and Drug Administration (FDA) cleared nano-sensor technology for monitoring blood pressure every 10 seconds. LiveOne is a wrist-worn, cuff-free solution that provides real time measurements to improve the care and treatment of people with hypertension and cardiovascular diseases. The non-invasive device requires no external calibration and continuously extracts the pressure waveform out of the radial artery. The LiveOne monitoring service will be available through health systems, health insurers, and self-insured employers for people with high blood pressure and cardiovascular disease.

Key Points: 
  • DENVER and LUXEMBOURG, June 30, 2022 /PRNewswire/ -- LiveMetric , a leader in medical wearable technology, today announcedthe launch of LiveOne, the world's first 510(k) U.S. Food and Drug Administration (FDA) cleared nano-sensor technology for monitoring blood pressure every 10 seconds.
  • The LiveOne monitoring service will be available through health systems, health insurers, and self-insured employers for people with high blood pressure and cardiovascular disease.
  • "Its innovative design provides an affordable, daily monitor which empowers users to know their blood pressurefrom anywhere and at any time.
  • The LiveMetric platform allows for third parties to manage a patient's condition through an easy integration to the LiveMetric platform.

Global Balloon Catheter Market Report 2022-2027: Coronary Artery Disease Segment Leads the Market - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 28, 2022
General Health, Health, Medical Devices, Coronary artery disease, WHO, Awareness, World Health Organization, Death, Blood, World Heart Federation, Patient, CVD, Catheter, COVID-19, Balloon catheter, Femoral artery, Prevalence, Circulatory system, Anatomy, Woman, Cardiac catheterization, CAGR, Heart, Trends and Other Diseases, World, Medical tourism, Cholesterol, Diabetes, Moyamoya disease, Conditional sentence, Industry, Radial artery, Atherosclerosis, Cardiovascular disease, Peripheral artery disease, Man, Renewable energy, Pharmaceutical industry, Medical imaging, Health insurance, Growth

The "Global Balloon Catheter Market, Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Balloon Catheter Market, Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The balloon catheter is mostly utilized to treat heart-related diseases caused due to diabetes, high blood pressure, specifically coronary heart disease, and high cholesterol levels in the blood.
  • They are frequently used in varied applications like Coronary Artery Disease, Peripheral Vascular Disease, and Neurovascular Diseases that require the balloon to occlude the anatomy.
  • In terms of application, the Balloon Catheter market can be segmented into Coronary Artery Disease, Peripheral Vascular Disease, Neurovascular Diseases, and Others Diseases.

Surmodics Announces Successful First Patient Uses of Sublime™ Radial Access .018 RX PTA Dilatation Catheter

Retrieved on: 
Wednesday, September 29, 2021
Health, Medical Devices, Cardiology, Radial artery, Libin Cardiovascular Institute of Alberta, Peripheral artery disease, Veni, vidi, vici, PTA, Annual report, Investor, NASDAQ, FDA, Patient satisfaction, Physician, American Heart Association, Nursing, FCCP, PAD, IVD, Radial, CEO, Transradial catheterization, RX, Company, Access, Growth, Disease, Stroke, Risk, Comparison, Acute coronary syndrome, Forward-looking statement, Foot, Sublime, Genomics, Precision medicine, SEC, Medical imaging, Wood drying, Pharmaceutical industry

The device is the latest addition to the Sublime Radial Access Platform, joining the Sublime Radial Access Guide Sheath and the Sublime Radial Access .014 RX PTA Dilatation Catheter.

Key Points: 
  • The device is the latest addition to the Sublime Radial Access Platform, joining the Sublime Radial Access Guide Sheath and the Sublime Radial Access .014 RX PTA Dilatation Catheter.
  • Sublime Radial Access RX PTA Dilatation Catheters will allow physicians to treat the most distal blockages in the foot with just radial access.
  • This Sublime Radial Access .018 RX PTA Dilatation Catheter is a great addition to the current devices available for minimal arterial access lower extremity intervention (MLEI) procedures, added Dr. Ansaarie.
  • We are thrilled that Dr. Lodha and Dr. Ansaarie pioneered these first cases with the Sublime Radial Access .018 RX PTA Dilatation Catheter, said Gary Maharaj, president and CEO of Surmodics.